Obesity — the major groups of its complications
DOI:
https://doi.org/10.12775/QS.2026.54.70426Keywords
obesity, metabolic syndrome, pediatric development, postural balance, cardiovascular disease, 21st-century pandemicAbstract
Background: Obesity has evolved from a simple metabolic condition into a complex, chronic systemic disease that has reached pandemic proportions in the 21st century. It serves as a primary driver for a multitude of chronic pathologies across virtually every human organ system.
Aim: This narrative review aims to provide a comprehensive analysis of the major groups of obesity complications, exploring their pathophysiological mechanisms and epidemiological impact across the lifespan, with a focus on pediatric development and geriatric well-being.
Material and methods: A systematic search of PubMed, MEDLINE, Google Scholar. Selection criteria prioritized peer-reviewed articles, meta-analyses, and cohort studies published between 2014 and 2026, focusing on the mechanisms of metabolic, cardiovascular, respiratory, musculoskeletal, and psychosocial impairment.
Results: Metabolic complications of obesity include type 2 diabetes and hyperuricemia, while cardiovascular effects range from hypertension to coronary artery disease. Respiratory health is compromised by mechanical and inflammatory pathways, leading to obstructive sleep apnea and hypoventilation. Pediatric studies demonstrate that excessive weight significantly accelerates skeletal and dental maturation, while geriatric data highlight severe declines in self-esteem and social integration.
Conclusions: The complications of obesity are intrinsically linked to chronic low-grade inflammation and hormonal dysregulation. Management must move beyond simple weight loss to address the systemic inflammatory environment and the varied psychosocial consequences.
References
1. Panasiuk, D., Szponarowicz, P., Panek, E., Jasłowski, D., Rzeszutko, M., Raczkiewicz, P., Skrętowicz, M., Snopkowski, B., Korzec, T., & Sosnowski, J. (2023). Obesity of children and adults – pandemic of the 21st century. Journal of Education, Health and Sport, 22(1), 36–45. https://doi.org/10.12775/JEHS.2023.22.01.003
2. Olszewska, K., Mielnik-Błaszczak, M., Plechawska, P., & Przybyś, J. (2018). Overweight and obesity affect skeletal maturation and dental development in children and adolescents – a retrospective study. Journal of Education, Health and Sport, 8(6), 139–152. https://apcz.umk.pl/JEHS/article/view/5524
3. Chandrasekaran, P., & Weiskirchen, R. (2024). The signaling pathways in obesity‑related complications. Journal of Cell Communication and Signaling, 18(2), e12039. https://doi.org/10.1002/ccs3.12039
4. Nammi, S., Koka, S., Chinnala, K. M., & Boini, K. M. (2004). Obesity: an overview on its current perspectives and treatment options. Nutrition journal, 3, 3. https://doi.org/10.1186/1475-2891-3-3
5. Gilden, A. H., & Catenacci, V. A. (2024). Obesity clinical features. Annals of Internal Medicine, 177(5), ITC65–ITC80. https://doi.org/10.7326/AITC202405210
6. Chilimoniuk, Z., Borkowska, A., Chałupnik, A., Raksa, K., Sobstyl, A., & Piecewicz‑Szczęsna, H. (2018). The problem of obesity and overweight among children and youth in the world. Journal of Education, Health and Sport, 8(9), 1541–1547. https://doi.org/10.5281/zenodo.1436406
7. Jakubiec, J., Gmitrzuk, J., Malinka, Z., Wiśniewska, K., Jachymek, A., Opatowska, M., Kucharski, T., & Karasiński, M. (2024). Obesity in adults: Causes, health consequences, and treatment methods. Quality in Sport, 17, 53051. https://doi.org/10.12775/qs.2024.17.53051
8. Moursi, N., Tanofsky-Kraff, M., & Parker, M. (2023). Changes in food consumption, BMI, and body composition in youth during COVID-19. International Journal of Environmental Research and Public Health, 20(18), 6796. https://doi.org/10.3390/ijerph20186796
9. Ferentinou, M., Georgiou, C., Kyriakou, E., Papadopoulou, A., & Stylianou, K. (2023). The impact of the COVID-19 pandemic on childhood obesity: A review. Cureus, 15(9), e45470. https://doi.org/10.7759/cureus.45470
10. Romaniuk, M., Wachowska, M., Sowiński, W., Rycąbel, P. M., Szymura, M., Molenda, M. J., Woszczyńska, O., Wojciechowska, A. E., Krawczyk, M., & Paniak, M. (2025). Modern approaches to obesity treatment – literature review. Quality in Sport, 41, 60022. https://doi.org/10.12775/QS.2025.41.60022
11. Acosta, A., Subramanian, S., Smith, J., & Jones, R. (2021). Selection of antiobesity medications based on phenotypes enhances weight loss. Obesity (Silver Spring), 29(4), 662–671. https://doi.org/10.1002/oby.23120
12. Borończyk, A., Bioły, A., Marcjasz, P., Buliszak, A., Babczyńska, M., Kucia, K., Hrapkowicz, R., & Zając, P. (2025). Hyperuricemia in obese children: Diagnostic challenges, pathophysiological mechanisms, and therapeutic approaches. Quality in Sport, 41, 60115. https://doi.org/10.12775/QS.2025.41.60115.
13. Man-Fung Tsoi, Hang-Long Li, Qi Feng, Ching-Lung Cheung, Tommy T. Cheung, Bernard M.Y. Cheung; Prevalence of Childhood Obesity in the United States in 1999–2018: A 20-Year Analysis. Obes Facts 3 August 2022; 15 (4): 560–569. https://doi.org/10.1159/000524261
14. World Health Organization. (2000). Obesity: Preventing and managing the global epidemic (WHO Technical Report Series No. 894, pp. 1–253). World Health Organization. https://www.who.int/publications/i/item/9241208945
15. Wang, X., Hunter, D., Xu, J., & Ding, C. (2015). Metabolic triggered inflammation in osteoarthritis. Osteoarthritis and Cartilage, 23(1), 22–30. https://doi.org/10.1016/j.joca.2014.10.002
16. Zhou, Y., Chi, J., Lv, W., & Wang, Y. (2021). Obesity and diabetes as high-risk factors for severe COVID-19. Diabetes/Metabolism Research and Reviews, 37, e3377. https://doi.org/10.1002/dmrr.3377
17. Lee, E. Y., & Yoon, K. H. (2018). Epidemic obesity in children: Risk factors. Frontiers of Medicine, 12(6), 658–666. https://doi.org/10.1007/s11684-018-0640-1
18. Skoczyńska, M., Chowaniec, M., Szymczak, A., Langner‑Hetmańczuk, A., Maciążek‑Chyra, B., & Wiland, P. (2020). Pathophysiology of hyperuricemia and its clinical significance: A narrative review. Reumatologia, 58(5), 312–323. https://doi.org/10.5114/reum.2020.100140
19. Lima, W. G., Martins‑Santos, M. E. S., & Chaves, V. E. (2015). Uric acid as a modulator of glucose and lipid metabolism. Biochimie, 116, 17–23. https://doi.org/10.1016/j.biochi.2015.06.025
20. Copur, S., Demiray, A., & Kanbay, M. (2022). Uric acid in metabolic syndrome: Does uric acid have a definitive role? European Journal of Internal Medicine, 103, 4–12. https://doi.org/10.1016/j.ejim.2022.04.022
21. Dolepski, K., Duszyńska, K., Góral, A., Żuk, K., & Czachajda, M. (2025). Childhood obesity – risk factors and consequences of the disease. Quality in Sport, 39, 1–14. https://doi.org/10.12775/QS.2025.39.59095
22. Sahle, B. W., Rebar, A. L., Loxton, D., Hay, P., Touyz, S., & Hiller, J. E. (2019). Association between depression, anxiety and weight change in young adults. BMC Psychiatry, 19(1), 398. https://doi.org/10.1186/s12888-019-2385-z
23. Kohl, H. W., Craig, C. L., Lambert, E. V., Inoue, S., Alkandari, J. R., Leetongin, G., & Kahlmeier, S. (2012). The pandemic of physical inactivity: Global action for public health. The Lancet, 380(9838), 294–305. https://doi.org/10.1016/S0140-6736(12)60898-8
24. Atkins, J. L., Whincup, P. H., Morris, R. W., Lennon, L. T., Papacosta, O., & Wannamethee, S. G. (2014). Sarcopenic obesity and risk of cardiovascular disease and mortality: A population‑based cohort study of older men. Journal of the American Geriatrics Society, 62(2), 253–260. https://doi.org/10.1111/jgs.12652
25. Makuch, R., Kucharski, A., Pilarski, K., Chrościcka , A., Gała, K., Czajka, A., … Wawrzyniak, A. M. (2024). Impact of Obesity on Respiratory Health: The Role of Sport and Physical Activity in Prevention and Management. Quality in Sport, 15, 52231. https://doi.org/10.12775/QS.2024.15.52231
26. Kaw, R., Wong, J., & Mokhlesi, B. (2021). Obesity and obesity hypoventilation, sleep hypoventilation, and postoperative respiratory failure. Anesthesia & Analgesia, 132(5), 1265–1273. https://doi.org/10.1213/ANE.0000000000005352
27. Grunstein, R. R., & Wilcox, I. (1994). Sleep-disordered breathing and obesity. Bailliere's clinical endocrinology and metabolism, 8(3), 601–628. https://doi.org/10.1016/s0950-351x(05)80288-5
28. Smolen, J., et al. (2024). Obesity impact on bones and joints health. Journal of Education, Health and Sport, 75, 55986. https://doi.org/10.12775/JEHS.2024.75.55986
29. Koskinen, A., Vuolteenaho, K., Nieminen, R., Moilanen, T., & Moilanen, E. (2011). Leptin enhances MMP‑1, MMP‑3 and MMP‑13 production in human osteoarthritic cartilage and correlates with MMP‑1 and MMP‑3 in synovial fluid from OA patients. Clinical and Experimental Rheumatology, 29(1), 57–64. https://pubmed.ncbi.nlm.nih.gov/21345293
30. Pankanin, E. S. (2018). The impact of excessive body weight on postural balance. Journal of Education, Health and Sport, 8(7), 313–321. Retrieved from https://apcz.umk.pl/JEHS/article/view/5666
31. Pankanin, E. S., Dobosiewicz, A. M., & Miętkowska, P. (2018). Static posturography as an instrument to assess the balance among athletes. Journal of Education, Health and Sport, 8(5), 216–225. Retrieved from https://apcz.umk.pl/JEHS/article/view/5495
32. Steinberg, N., Nemet, D., Pantanowitz, M., Zeev, A., Hallumi, M., Sindiani, M., Meckel, Y., & Eliakim, A. (2016). Longitudinal Study Evaluating Postural Balance of Young Athletes. Perceptual and motor skills, 122(1), 256–279. https://doi.org/10.1177/0031512516628989.
33. Shalitin, S., & Gat‑Yablonski, G. (2022). Associations of obesity with linear growth and puberty. Hormone Research in Paediatrics, 95(2), 120–136. https://doi.org/10.1159/000516171
34. Szkutnicka, E., Samardakiewicz, M., Barańska, A., Sokołowska, A., Firlej, E., & Szkutnicki, H. (2018). The effects of obesity on the life activity and self-esteem of the elderly. Journal of Education, Health and Sport, 8(4), 11–19. https://doi.org/10.5281/zenodo.1213295
35. Jakubiec, J., et al. (2024). Tirzepatide efficacy and safety profile: A review. Quality in Sport, 17, 53102. https://doi.org/10.12775/QS.2024.17.53102
36. Véniant, M.M., Lu, SC., Atangan, L. et al. A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nat Metab 6, 290–303 (2024). https://doi.org/10.1038/s42255-023-00966-w
37. Štempeľová, I., Takáč, O., & Hudáková, H. (2023). Obesity as a 21st century pandemic. International Journal of Advanced Natural Sciences and Engineering Researches, 7, 449–454. https://doi.org/10.59287/ijanser.1187
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aleksandra Rucka, Michał Rucki, Nikodem Cieleban, Magdalena Modliborska, Mateusz Kowalski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 16
Number of citations: 0
